Wednesday, January 30, 2013

• AbbVie CEO Says Humira Will Blunt $1B Hit To Lipid Franchiseat Forbes (Wed, Jan 30)
• 7 Dividend Stocks With Low Payout Ratios Undervalued By Free Cash Flow Yieldsat Seeking Alpha (Wed, Jan 30)

Tuesday, January 29, 2013

• XL Group Takes Over #194 Spot From Amgenat Forbes (Tue, Jan 29)
• U.S. Stock Options With Biggest Changes in Implied Volatilityat Bloomberg (Tue, Jan 29)
• Three Takeaways From This Biotech Giant's 2012 Earningsat Motley Fool (Tue, Jan 29)
• Amgen Inc Stock Buy Recommendation Reiterated (AMGN)at TheStreet (Tue, Jan 29)

Monday, January 28, 2013

• Keryx: This Biotech Is No Zombieat Motley Fool (Mon, Jan 28)
• Illumina posts gain in 4Q on business unit saleAP (Mon, Jan 28)
• Amgen Rises On Unusually High Volume (AMGN)at TheStreet (Mon, Jan 28)
• Keryx Rises on Results of Phosphorous-Lowering Drug Studyat Bloomberg (Mon, Jan 28)
• Statins Beware?at Motley Fool (Mon, Jan 28)
• Statins Beware?at Motley Fool (Mon, Jan 28)
• Kudos To Keryx, But Can Zerenex Zing?at TheStreet (Mon, Jan 28)
• Amgen's Neulasta Succeeds in Phase 3 Cancer Trialat Motley Fool (Mon, Jan 28)
• The Zacks Analyst Blog Highlights: Amgen, Celgene, Gilead Sciences, Vertex Pharmaceuticals and Nasdaq Biotechnology Index ETFZacks (Mon, Jan 28)

Saturday, January 26, 2013

• Bristol-Myers Squibb and 3 Top Pharma Stocks with Earnings Investors Must Seeat Wall St. Cheat Sheet (Sat, Jan 26)
• Amgen Phase lll PAVES Study evaluating Neulasta met primary endpointtheflyonthewall.com (Sat, Jan 26)

Friday, January 25, 2013

• It's All Relative for This Biotech Underperformerat Motley Fool (Fri, Jan 25)
• Safest Way to Play BiotechZacks (Fri, Jan 25)
• [video] Market Winners & Losers: Travel, Health Care & Moreat CNBC (Fri, Jan 25)
• Stephen Brozak: Changing The Way Money Is Made And Diseases Are Curedat Seeking Alpha (Fri, Jan 25)
• Agrium Upgraded to Buy and 4 Upgraded Stocks to Noteat Wall St. Cheat Sheet (Fri, Jan 25)
• Threshold Pharmaceuticals Rises on Hope for Cancer Drugat Minyanville (Fri, Jan 25)
• Amgen upgraded to Buy from Hold at Argustheflyonthewall.com (Fri, Jan 25)

Thursday, January 24, 2013

• Can Biologics Make You Rich?at Motley Fool (Thu, Jan 24)

Add AMGN News to My Yahoo!